Time for total shift to first-trimester screening for Down's syndrome

Lancet

Volumn 358, Issue 9294, 2001, Pages 1658-1659

  Cuckle, Howard ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A; PROTEIN A;

ANEUPLOIDY; DISEASE MARKER; DOWN SYNDROME; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; MATERNAL AGE; NEURAL TUBE DEFECT; NOTE; PREDICTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

EID: 0035904768     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06724-1     Document Type: Note

References (12)

1. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities
2. Maternal serum alpha-fetoprotein measurement: A screening test for Down syndrome
3. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level
4. Antenatal screening for Down's syndrome
5. Maternal serum screening for Down syndrome in early pregnancy
6. Biochemical screening for Down syndrome
7. Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy
8. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
9. Correct estimation of parameters for ultrasound nuchal translucency screening
10. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency
11. One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester
12. Integrating Down's syndrome screening